Based on the forecast data for liver malignant neoplasms mortality among females in Canada, the mortality rate is expected to increase gradually from 1.29 thousand in 2024 to 1.4 thousand by 2028. Compared to recent trends in previous years, this signifies a consistent upward trend. In 2023, the mortality rate was at a certain baseline from which this growth trajectory has begun. The year-on-year growth rates highlight a stable increase ranging from approximately 2.32% to 2.54% annually, leading to a Compound Annual Growth Rate (CAGR) of about 2.08% over this five-year forecast period.
Future trends to watch include the impact of advanced medical interventions and early detection initiatives on liver cancer mortality rates. Additionally, any significant changes in environmental factors or healthcare accessibility could alter forecasted outcomes.
